A new study from IHE, published in Psoriasis: Targets and Therapies, reports the economic burden of generalized pustular psoriasis (GPP) in Sweden. GPP is a severe form of psoriasis, characterized by the presence of sterile pustules over the body.
Using Swedish register data, researchers at IHE have investigated the use of healthcare resources and drugs among patients with GPP in comparison to both the general population and to people with the more common type of psoriasis, psoriasis vulgaris. They have also estimated and compared healthcare costs between the groups.
The study shows that healthcare costs for patients with GPP were approximately 3 times higher than for the general population, and nearly double compared to people with psoriasis vulgaris. The higher costs for GPP were largely represented by a higher use of inpatient care and biologic drugs.
The results, which are in line with international studies, highlight a need for more efficient therapeutic options for patients with GPP.
Psoriasis: Targets and Therapy 2022; 2022(12): 89-98